Home > Formulary : Adult > Recent Decisions > 2019 >
Decisions 23rd July 2019
At the meeting on the 23rd July the following decisions were agreed:
New Drug Requests
Approved
Methylphenidate IR Formulation (Amber SCP)
Shared Care Protocol/ TLS Change in status
Ranolazine (Amber SCP)
-
Updated SCP
Further work needed
Utrogestan
-
Further work is needed to clarify whether this will be placed in the local HRT pathway after first line oral therapies
Cinacalcet
-
Further work is needed in regards to the evidence for monitoring arrangements for patients with complex primary hyperparathyroidism in adults
Dexamfetamine
-
Change from TLS Red to TLS Amber 3 months for ADHD pending shared care protocol